Documentation Hospitals Medication Dispensing 
Proxsys Rx
APRIL 4, 2024
(Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Today, hospitals and other 340B covered entities can acquire many specialty drugs for as little as 1¢ — which happens when a drug has hit its 100% Medicaid rebate cap.
Proxsys Rx
AUGUST 22, 2023
(Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Today, hospitals and other 340B covered entities can acquire many specialty drugs for as little as 1¢ — which happens when a drug has hit its 100% Medicaid rebate cap.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
DECEMBER 22, 2023
(Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Today, hospitals and other 340B covered entities can acquire many specialty drugs for as little as 1¢ — which happens when a drug has hit its 100% Medicaid rebate cap.
FDA Law Blog: Biosimilars
OCTOBER 17, 2023
Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).
Pharmacy Times
JUNE 17, 2025
This research shows the impactful interventions implemented within a medically integrated pharmacy (MIP) model, specifically focusing on how oncology-trained nurses can leverage comprehensive chart reviews and reassessments to identify discrepancies before medication dispensation, ultimately leading to substantial cost avoidance and waste reduction.
Proxsys Rx
JUNE 4, 2025
The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. REDUCED COST SAVINGS: Hospitals often rely on specialty pharmacy revenue to support uncompensated care. 1) Sanofi v. HHS (2023) Court: U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content